Gabby DeGravina | Investor Relations |
Frank Bedu-Addo | Chief Executive Officer |
Matt Hill | Chief Financial Officer |
Lauren V. Wood | Chief Medical Officer |
Louise Chen | Cantor Fitzgerald |
Leland Gershell | Oppenheimer |
Andy Fleszar | B. Riley Securities |
Robert LeBoyer | Noble Capital Markets |
James Molloy | Alliance Global Partners |
Hello, and welcome to the PDS Biotechnology First Quarter 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to your host, Gabby DeGravina, Investor Relations. Please go ahead, Gabby.